- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 40.5M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $392.27M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $368.36M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $531K |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $524K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $91.65M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $108.12M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $107.5M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $111.84M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $529.55M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $509.02M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $219.9M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $218.05M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.38B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.38B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 29.52M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $45K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$23.58M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $526.4M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $333.07M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.62 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.62 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $15.77M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$18.29M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$26.74M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $26.06M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $44.02M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $70.07M |